Cambridge, Mass., USA and Tel Aviv, Israel – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Nuvo Group, a private company commercializing INVU by Nuvo™, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform, today announced a collaboration to develop a more inclusive pregnancy care experience from the prenatal stage through labor and delivery. Through the collaboration, Philips will support Nuvo in facilitating remote fetal monitoring pilot programs that focus on increasing access and adherence to prescribed care in remote areas, beginning with a pilot program in rural Colorado.
More than half (54 percent) of the counties in the USA offer very limited or no access to maternity care . Within these counties, more than 2.2 million women of childbearing age live in full maternity care deserts, which have no hospital offering obstetric care, no birth center, and no obstetric provider . Following the recent White House call to action for organizations to help improve health outcomes for parents and infants, Philips and Nuvo will collaborate to pilot Nuvo’s INVU pregnancy monitoring system as part of an integrated solution for rural care providers and their patients in the USA.